Cargando…
Antibody efficacy of inactivated vaccine boosters (CoronaVac) against Omicron variant from a 15-month follow-up study
| Autores principales: | , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
The British Infection Association. Published by Elsevier Ltd.
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9233874/ https://www.ncbi.nlm.nih.gov/pubmed/35760302 http://dx.doi.org/10.1016/j.jinf.2022.06.018 |
| _version_ | 1784735906729558016 |
|---|---|
| author | Yin, Yue Li, Xinjie Qian, Chungen Cheng, Bangning Lu, Fengmin Shen, Tao |
| author_facet | Yin, Yue Li, Xinjie Qian, Chungen Cheng, Bangning Lu, Fengmin Shen, Tao |
| author_sort | Yin, Yue |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-9233874 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | The British Infection Association. Published by Elsevier Ltd. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-92338742022-06-27 Antibody efficacy of inactivated vaccine boosters (CoronaVac) against Omicron variant from a 15-month follow-up study Yin, Yue Li, Xinjie Qian, Chungen Cheng, Bangning Lu, Fengmin Shen, Tao J Infect Letter to the Editor The British Infection Association. Published by Elsevier Ltd. 2022-10 2022-06-26 /pmc/articles/PMC9233874/ /pubmed/35760302 http://dx.doi.org/10.1016/j.jinf.2022.06.018 Text en © 2022 The British Infection Association. Published by Elsevier Ltd. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
| spellingShingle | Letter to the Editor Yin, Yue Li, Xinjie Qian, Chungen Cheng, Bangning Lu, Fengmin Shen, Tao Antibody efficacy of inactivated vaccine boosters (CoronaVac) against Omicron variant from a 15-month follow-up study |
| title | Antibody efficacy of inactivated vaccine boosters (CoronaVac) against Omicron variant from a 15-month follow-up study |
| title_full | Antibody efficacy of inactivated vaccine boosters (CoronaVac) against Omicron variant from a 15-month follow-up study |
| title_fullStr | Antibody efficacy of inactivated vaccine boosters (CoronaVac) against Omicron variant from a 15-month follow-up study |
| title_full_unstemmed | Antibody efficacy of inactivated vaccine boosters (CoronaVac) against Omicron variant from a 15-month follow-up study |
| title_short | Antibody efficacy of inactivated vaccine boosters (CoronaVac) against Omicron variant from a 15-month follow-up study |
| title_sort | antibody efficacy of inactivated vaccine boosters (coronavac) against omicron variant from a 15-month follow-up study |
| topic | Letter to the Editor |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9233874/ https://www.ncbi.nlm.nih.gov/pubmed/35760302 http://dx.doi.org/10.1016/j.jinf.2022.06.018 |
| work_keys_str_mv | AT yinyue antibodyefficacyofinactivatedvaccineboosterscoronavacagainstomicronvariantfroma15monthfollowupstudy AT lixinjie antibodyefficacyofinactivatedvaccineboosterscoronavacagainstomicronvariantfroma15monthfollowupstudy AT qianchungen antibodyefficacyofinactivatedvaccineboosterscoronavacagainstomicronvariantfroma15monthfollowupstudy AT chengbangning antibodyefficacyofinactivatedvaccineboosterscoronavacagainstomicronvariantfroma15monthfollowupstudy AT lufengmin antibodyefficacyofinactivatedvaccineboosterscoronavacagainstomicronvariantfroma15monthfollowupstudy AT shentao antibodyefficacyofinactivatedvaccineboosterscoronavacagainstomicronvariantfroma15monthfollowupstudy |